PULMONX CORPORATION Shareholders' Equity
PULMONX CORPORATION (LUNG) had Shareholders' Equity of $39.20 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $39.20M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $45.76M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $54.12M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $60.03M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $39.20M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $45.76M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $54.12M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $60.03M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $69.09M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $77.67M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $85.81M 10-Q · filed 2026-08-04 | |
| 2024-09-30 | $93.92M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $101.18M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $110.50M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $118.31M 10-K · filed 2026-03-10 | |
| 2023-09-30 | $125.74M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | $133.95M 10-Q · filed 2024-11-01 | |
| 2023-03-31 | $143.93M 10-Q · filed 2024-11-01 | |
| 2022-12-31 | $154.01M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $163.48M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $172.18M 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $182.15M 10-Q · filed 2023-11-03 | |
| 2021-12-31 | $193.24M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $202.83M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $208.87M 10-Q · filed 2022-11-08 | $209.92M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $216.15M 10-Q · filed 2022-11-08 | $216.62M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $226.13M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$206.89M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$205.76M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | -$194.04M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | -$187.38M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$182.84M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | -$178.79M 10-Q · filed 2020-11-13 | |
| 2019-03-31 | -$173.41M 10-Q · filed 2020-11-13 | |
| 2018-12-31 | -$167.33M 10-K · filed 2021-03-15 | |
| 2017-12-31 | -$149.39M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |